戻る Agenda
Session 7: Orphan Medicines – Doing Studies in Small Populations
Session Chair(s)
To Be Announced
NA, Switzerland
Geneviève Le Visage, PharmD, MSc
Head EU RA Policy and Liaison
Novartis Pharma AG, Switzerland
Session 7: Orphan Medicines – Doing Studies in Small Populations
Speaker(s)
Feedback on the Joint Review of the Paediatric and Orphan Regulations
Fabio D’Atri
Unit B5 Directorate General for Health and Food Safey, European Commission , Belgium
Policy Officer, Deputy Head of Unit
Orphan Medicines for Paediatric Use - A focus on the European Union
Thomas Kühler, PhD, MSc
Sanofi R&D, France
Head GRSP EU/AMEE